Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (71-80 of 333) with videos related to

Pageof 34
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver DiseaseNicola Pugliese, Vincent Wai-Sun Wong, Jörn M Schattenberg, et al.
European Journal of Internal Medicine|April 28, 2026
Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statementReinhold Kreutz, Ali Canbay, Martin Haluzik, et al.
Advances in Therapy|July 9, 2026
Qualitative Evaluation of Fatigue and Pruritus Among Patients with Primary Biliary CholangitisCynthia Levy, Betsy Williams, France Ginchereau Sowell, et al.
Hepatology Communications|October 27, 2023
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib studyEric J Lawitz, Thomas Reiberger, Jörn M Schattenberg, et al.
Scientific Reports|March 10, 2019
Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLDNadine Gehrke, Jana Biedenbach, Yvonne Huber, et al.
Deutsches Arzteblatt International|February 9, 2021
Tumor Incidence in Patients with Non-Alcoholic Fatty Liver DiseaseYvonne Huber, Christian Labenz, Maurice Michel, et al.
Gastro Hep Advances|August 12, 2024
Identification of Fast Progressors Among Patients With Nonalcoholic Steatohepatitis Using Machine LearningJörn M Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, et al.
United European Gastroenterology Journal|June 27, 2020
Patterns of liver injury in COVID-19 - a German case seriesJörn M Schattenberg, Christian Labenz, Marcus-Alexander Wörns, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinomaMaurice Michel, Eva Kalliga, Christian Labenz, et al.
European Journal of Clinical Nutrition|September 3, 2023
Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic reviewArpita Das, Yu Lung Malcolm Tang, Nora A Althumiri, et al.
Pageof 34

Showing results (71-80 of 333) with videos related to

Sort By:
Pageof 34
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver DiseaseNicola Pugliese, Vincent Wai-Sun Wong, Jörn M Schattenberg, et al.
European Journal of Internal Medicine|April 28, 2026
Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statementReinhold Kreutz, Ali Canbay, Martin Haluzik, et al.
Advances in Therapy|July 9, 2026
Qualitative Evaluation of Fatigue and Pruritus Among Patients with Primary Biliary CholangitisCynthia Levy, Betsy Williams, France Ginchereau Sowell, et al.
Hepatology Communications|October 27, 2023
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib studyEric J Lawitz, Thomas Reiberger, Jörn M Schattenberg, et al.
Scientific Reports|March 10, 2019
Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLDNadine Gehrke, Jana Biedenbach, Yvonne Huber, et al.
Deutsches Arzteblatt International|February 9, 2021
Tumor Incidence in Patients with Non-Alcoholic Fatty Liver DiseaseYvonne Huber, Christian Labenz, Maurice Michel, et al.
Gastro Hep Advances|August 12, 2024
Identification of Fast Progressors Among Patients With Nonalcoholic Steatohepatitis Using Machine LearningJörn M Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, et al.
United European Gastroenterology Journal|June 27, 2020
Patterns of liver injury in COVID-19 - a German case seriesJörn M Schattenberg, Christian Labenz, Marcus-Alexander Wörns, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinomaMaurice Michel, Eva Kalliga, Christian Labenz, et al.
European Journal of Clinical Nutrition|September 3, 2023
Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic reviewArpita Das, Yu Lung Malcolm Tang, Nora A Althumiri, et al.
Pageof 34